Literature DB >> 22370855

Selecting and isolating colonies of human induced pluripotent stem cells reprogrammed from adult fibroblasts.

Urszula Polak1, Calley Hirsch, Sherman Ku, Joel Gottesfeld, Sharon Y R Dent, Marek Napierala.   

Abstract

Herein we present a protocol of reprogramming human adult fibroblasts into human induced pluripotent stem cells (hiPSC) using retroviral vectors encoding Oct3/4, Sox2, Klf4 and c-myc (OSKM) in the presence of sodium butyrate (1-3). We used this method to reprogram late passage (>p10) human adult fibroblasts derived from Friedreich's ataxia patient (GM03665, Coriell Repository). The reprogramming approach includes highly efficient transduction protocol using repetitive centrifugation of fibroblasts in the presence of virus-containing media. The reprogrammed hiPSC colonies were identified using live immunostaining for Tra-1-81, a surface marker of pluripotent cells, separated from non-reprogrammed fibroblasts and manually passaged (4,5). These hiPSC were then transferred to Matrigel plates and grown in feeder-free conditions, directly from the reprogramming plate. Starting from the first passage, hiPSC colonies demonstrate characteristic hES-like morphology. Using this protocol more than 70% of selected colonies can be successfully expanded and established into cell lines. The established hiPSC lines displayed characteristic pluripotency markers including surface markers TRA-1-60 and SSEA-4, as well as nuclear markers Oct3/4, Sox2 and Nanog. The protocol presented here has been established and tested using adult fibroblasts obtained from Friedreich's ataxia patients and control individuals( 6), human newborn fibroblasts, as well as human keratinocytes.

Entities:  

Mesh:

Year:  2012        PMID: 22370855      PMCID: PMC3376935          DOI: 10.3791/3416

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  15 in total

Review 1.  Guidelines and techniques for the generation of induced pluripotent stem cells.

Authors:  Nimet Maherali; Konrad Hochedlinger
Journal:  Cell Stem Cell       Date:  2008-12-04       Impact factor: 24.633

2.  Butyrate greatly enhances derivation of human induced pluripotent stem cells by promoting epigenetic remodeling and the expression of pluripotency-associated genes.

Authors:  Prashant Mali; Bin-Kuan Chou; Jonathan Yen; Zhaohui Ye; Jizhong Zou; Sarah Dowey; Robert A Brodsky; Joyce E Ohm; Wayne Yu; Stephen B Baylin; Kosuke Yusa; Allan Bradley; David J Meyers; Chandrani Mukherjee; Philip A Cole; Linzhao Cheng
Journal:  Stem Cells       Date:  2010-04       Impact factor: 6.277

Review 3.  Constructing and deconstructing stem cell models of neurological disease.

Authors:  Steve S W Han; Luis A Williams; Kevin C Eggan
Journal:  Neuron       Date:  2011-05-26       Impact factor: 17.173

4.  Generation of human induced pluripotent stem cells from dermal fibroblasts.

Authors:  W E Lowry; L Richter; R Yachechko; A D Pyle; J Tchieu; R Sridharan; A T Clark; K Plath
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-15       Impact factor: 11.205

5.  Adenoviral gene delivery can reprogram human fibroblasts to induced pluripotent stem cells.

Authors:  Wenbo Zhou; Curt R Freed
Journal:  Stem Cells       Date:  2009-11       Impact factor: 6.277

6.  Induction of pluripotent stem cells from adult human fibroblasts by defined factors.

Authors:  Kazutoshi Takahashi; Koji Tanabe; Mari Ohnuki; Megumi Narita; Tomoko Ichisaka; Kiichiro Tomoda; Shinya Yamanaka
Journal:  Cell       Date:  2007-11-30       Impact factor: 41.582

7.  Human induced pluripotent stem cells free of vector and transgene sequences.

Authors:  Junying Yu; Kejin Hu; Kim Smuga-Otto; Shulan Tian; Ron Stewart; Igor I Slukvin; James A Thomson
Journal:  Science       Date:  2009-03-26       Impact factor: 47.728

8.  Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins.

Authors:  Dohoon Kim; Chun-Hyung Kim; Jung-Il Moon; Young-Gie Chung; Mi-Yoon Chang; Baek-Soo Han; Sanghyeok Ko; Eungi Yang; Kwang Yul Cha; Robert Lanza; Kwang-Soo Kim
Journal:  Cell Stem Cell       Date:  2009-05-28       Impact factor: 24.633

9.  A ROCK inhibitor permits survival of dissociated human embryonic stem cells.

Authors:  Kiichi Watanabe; Morio Ueno; Daisuke Kamiya; Ayaka Nishiyama; Michiru Matsumura; Takafumi Wataya; Jun B Takahashi; Satomi Nishikawa; Shin-ichi Nishikawa; Keiko Muguruma; Yoshiki Sasai
Journal:  Nat Biotechnol       Date:  2007-05-27       Impact factor: 54.908

10.  piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells.

Authors:  Knut Woltjen; Iacovos P Michael; Paria Mohseni; Ridham Desai; Maria Mileikovsky; Riikka Hämäläinen; Rebecca Cowling; Wei Wang; Pentao Liu; Marina Gertsenstein; Keisuke Kaji; Hoon-Ki Sung; Andras Nagy
Journal:  Nature       Date:  2009-03-01       Impact factor: 49.962

View more
  8 in total

Review 1.  Expanded complexity of unstable repeat diseases.

Authors:  Urszula Polak; Elizabeth McIvor; Sharon Y R Dent; Robert D Wells; Marek Napierala
Journal:  Biofactors       Date:  2012-12-11       Impact factor: 6.113

2.  Excision of Expanded GAA Repeats Alleviates the Molecular Phenotype of Friedreich's Ataxia.

Authors:  Yanjie Li; Urszula Polak; Angela D Bhalla; Natalia Rozwadowska; Jill Sergesketter Butler; David R Lynch; Sharon Y R Dent; Marek Napierala
Journal:  Mol Ther       Date:  2015-03-11       Impact factor: 11.454

3.  Premature transcription termination at the expanded GAA repeats and aberrant alternative polyadenylation contributes to the Frataxin transcriptional deficit in Friedreich's ataxia.

Authors:  Yanjie Li; Jixue Li; Jun Wang; Siyuan Zhang; Keith Giles; Thazha P Prakash; Frank Rigo; Jill S Napierala; Marek Napierala
Journal:  Hum Mol Genet       Date:  2022-10-10       Impact factor: 5.121

4.  Alleviating GAA Repeat Induced Transcriptional Silencing of the Friedreich's Ataxia Gene During Somatic Cell Reprogramming.

Authors:  Urszula Polak; Yanjie Li; Jill Sergesketter Butler; Marek Napierala
Journal:  Stem Cells Dev       Date:  2016-10-17       Impact factor: 3.272

5.  Establishment and Maintenance of Primary Fibroblast Repositories for Rare Diseases-Friedreich's Ataxia Example.

Authors:  Yanjie Li; Urszula Polak; Amanda D Clark; Angela D Bhalla; Yu-Yun Chen; Jixue Li; Jennifer Farmer; Lauren Seyer; David Lynch; Jill S Butler; Marek Napierala
Journal:  Biopreserv Biobank       Date:  2016-03-22       Impact factor: 2.300

6.  Human skin hypoxia modulates cerebrovascular and autonomic functions.

Authors:  Olivia Pucci; Clifford Qualls; Anne Battisti-Charbonney; Dahlia Y Balaban; Joe A Fisher; Jim Duffin; Otto Appenzeller
Journal:  PLoS One       Date:  2012-10-08       Impact factor: 3.240

7.  Systematic evaluation of markers used for the identification of human induced pluripotent stem cells.

Authors:  Sumitha Prameela Bharathan; Kannan Vrindavan Manian; Syed Mohammed Musheer Aalam; Dhavapriya Palani; Prashant Ajit Deshpande; Mankuzhy Damodaran Pratheesh; Alok Srivastava; Shaji Ramachandran Velayudhan
Journal:  Biol Open       Date:  2017-01-15       Impact factor: 2.422

8.  Human Autopsy-Derived Scalp Fibroblast Biobanking for Age-Related Neurodegenerative Disease Research.

Authors:  Suet Theng Beh; Carlye Frisch; David A Brafman; Jared Churko; Jessica E Walker; Geidy E Serrano; Lucia I Sue; Eric M Reiman; Thomas G Beach; Lih-Fen Lue
Journal:  Cells       Date:  2020-10-30       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.